SEC Form 4 · accession 0001209191-15-057220
ZS Pharma, Inc. · ZSPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Srinivas Akkaraju
Director
Period of report
Jun 18, 2015
Accepted (ET)
Jun 29, 2015 · 6:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001459266
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | — | Jun 18, 2015 | A | 4,000 | A | — | — | Common Stock | 4,000 | 4,000 | D |
| Restricted Stock UnitF2 | — | Jun 18, 2015 | A | 1,000 | A | — | — | Common Stock | 1,000 | 1,000 | D |
Explanation of responses
- F1Mr. Akkaraju was granted an option to purchase 4,000 shares of common stock at an exercise price per share of $55.57 on June 18, 2015. This option vests in full on the earlier of the first anniversary of the date of grant or the date of the first annual meeting of the company's Stockholders that occurs after the date of grant, in each case subject to Mr. Akkaraju's continuing to serve as a member of the board of directors of the company and to the terms of the option agreement accompanying the grant.
- F2On June 18, 2015, Mr.Akkaraju was granted 1,000 restricted stock units representing the right to receive one share of common stock upon vesting of each restricted stock unit. The restricted stock units vest in full on the earlier of the first anniversary of the date of grant or the date of the first annual meeting of the company's Stockholders that occurs after the date of grant, in each case subject to Mr. Akkaraju's continuing to serve as a member of the board of directors of the company.